The mechanisms by which Yiqi Huoxue compound treats pulmonary inflammation and fibrosis in scleroderma: Based on bioinformatics and network pharmacology

• Hauptverfasser: Menghua HU (Verfasst von), Qiaorui TAN (Verfasst von), Weilin PU (Verfasst von), Min DU (Verfasst von), Wenzhen TU (Verfasst von), Dayan SUN (Verfasst von), Jingyi YANG (Verfasst von), Yifei GU (Verfasst von), Jiucun WANG (Verfasst von), Xiangzhen KONG (Verfasst von)
• Format: Buch
• Veröffentlicht: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology, 2024-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective To identify the effective components and key molecules of Yiqi Huoxu compound(YQHX) in the treatment of pulmonary inflammation and fibrosis in scleroderma, providing basis for the development of drug targets for scleroderma. Methods A mouse model of pulmonary fibrosis was established by a...